Skip To Main Content
Taobin Liu on Muck Rack

Taobin Liu

As seen in: Frontiers, Dove Medical Press, Aging
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Taobin

Contact Taobin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Knowledge, Attitudes, and Self‑Reported Practices Regarding Sleep‑Focused Delirium Prevention Among ICU Professionals: A Multicenter Survey in Jiangxi, China

|
By Xueting Yao, Taobin Liu, Zonglin Rao
| Dove Medical Press
Back to Journals » Nature and Science of Sleep » Volume 18 Authors Yao X, Rao Z, Liu T , Gao Y Received 14 April 2026 Accepted for publication 2 August 2026 Published 20 August 2026 Volume 2026:18 616912 DOI https://doi.org/10.2147/NSS.S616912 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof.
Open in Who Shared Issue with article?

Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma | Aging

|
By Xungang Li, Xinxi Deng, Taobin Liu, Wensheng Zhang
| Aging Verified
Purpose: Investigating the role of lncRNAs associated with the latest cell death mode (Disulfideptosis) in renal clear cell carcinoma, as well as their correlation with tumor prognosis, immune escape, immune checkpoints, tumor mutational burden, and malignant tumor progression. Searching for potential biomarkers and targets for renal clear cell carcinoma.
Open in Who Shared Issue with article?

Frontiers | Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone

|
By Ugo Falagario, Albino Eccher, Taobin Liu, Anthony C. Ng
| Frontiers
Introduction ​Prostate cancer (PCa) is an extremely common malignancy in men, its incidence being second only to lung cancer among all malignant tumors in men (1). Approximately 1.31 million new PCa cases are diagnosed each year globally, and nearly 10 million men currently have PCa. Out of these 10 million patients, approximately 700,000 suffer from metastatic PCa, which causes nearly 400,000 deaths each year, a death toll that is expected to more than double by 2040 (2).
Open in Who Shared Issue with article?
See all 3 articles